TrialFrontiers in immunology2020

Quantification of Bevacizumab Activity Following Treatment of Patients With Ovarian Cancer or Glioblastoma.

Christophe Lallemand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.